|
News: Latest in Breast Cancer
|
|
by hernews Posted: Fri., May 9, 2008, 10:08 pm
|
|
|
FRIDAY, May 9 (HealthDay News) -- Breast cancer patients are more than twice as likely to develop post-traumatic stress disorder if they have had previous mood and anxiety disorders, new research suggests.
About 16 percent of the 74 breast cancer patients studied by researchers at the Ohio State University Medical experienced PTSD 18 months after their cancer diagnosis. These same patients were three times more likely to have had anxiety disorders.
|
|
|
|
|
|
|
by hernews Posted: Fri., May 9, 2008, 10:45 am
|
|
|
FRIDAY, May 9 (HealthDay News) -- Breast cancer patients are more than twice as likely to develop post-traumatic stress disorder if they have had previous mood and anxiety disorders, new research suggests.
|
|
|
|
|
|
|
by hernews Posted: Thu., May 8, 2008, 07:22 am
|
|
|
By Steven Reinberg
EmpowHer's HealthDay Reporter
THURSDAY, May 8 (HealthDay News) -- While the rate at which breast cancer tumors grow varies among patients, that growth tends to be faster among younger women, Norwegian researchers report.
These findings may help in planning and evaluating screening programs, clinical trials and other studies, the researchers say.
|
|
|
|
|
|
|
by hernews Posted: Mon., May 5, 2008, 07:20 am
|
|
|
MONDAY, May 5 (HealthDay News) -- In women who have been diagnosed with breast cancer, having a known mutation in the BRCA 1 or 2 genes raises the risk of a second cancer, and many of these women choose to have their second breast removed before that has a chance to happen.
However, new research suggests that women who don't have these genetic mutations may still face an increased risk of a second cancer, especially if they have a family history of breast cancer or atypical breast cells.
|
|
|
|
|
|
|
by hernews Posted: Fri., May 2, 2008, 02:36 pm
|
|
|
FRIDAY, May 2 (HealthDay News) -- A number of potential new targets for treatments that block tumor blood vessel formation -- a key step in tumor growth and metastasis -- have been identified by researchers at the University of North Carolina at Chapel Hill.
|
|
|
|
|
|
|
|
|